Graham Corporation (GHM) Reports Q1: Everything You Need To Know Ahead Of Earnings
Graham Corporation missed analysts' revenue expectations by 5% last quarter, reporting revenues of $47.04 million, up 7.3% year on year. It was a mixed quarter for the company, with a solid beat of analysts' EPS estimates but full-year revenue guidance slightly missing analysts' expectations.
Is Graham Corporation a buy or sell going into earnings? Read our full analysis here, it's free.
This quarter, analysts are expecting Graham Corporation's revenue to grow 13.4% year on year to $55.67 million, in line with the 14% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.19 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Graham Corporation has missed Wall Street's revenue estimates twice over the last two years.
Looking at Graham Corporation's peers in the engineered components and systems segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Regal Rexnord's revenues decreased 8.4% year on year, beating analysts' expectations by 3%, and Arrow Electronics reported a revenue decline of 1.6%, topping estimates by 7.2%. Regal Rexnord traded up 13.6% following the results while Arrow Electronics was also up 3.6%.
Read our full analysis of Regal Rexnord's results here and Arrow Electronics's results here.
Investors in the engineered components and systems segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. Graham Corporation is up 16.5% during the same time and is heading into earnings with an average analyst price target of $52.67 (compared to the current share price of $42).
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Trump's Pay-For-Play Chips Deal Generates Alarm and Optimism
(Bloomberg) -- President Donald Trump's controversial plan to take a cut of revenue from chip sales to China is leading to concerns that the US government will find new ways to start charging companies for a range of business activities with other countries. Experts and people familiar with the matter said the surprise deal, in which Nvidia Corp. and Advanced Micro Devices Inc. agreed to pay 15% of their revenues from Chinese AI chip sales to the US, potentially provides a path to enter the Chinese market despite severe export controls, tariffs and other trade barriers. The US-Canadian Road Safety Gap Is Getting Wider Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets The question that companies must now confront is whether the risk is worth taking. People familiar with the matter, who asked not to be identified discussing private deliberations, said companies are struggling to figure out what the president's order means for their future, especially given the unpredictable nature of Trump's decision-making. 'This is truly bizarre and unusual, and the troubling thing — beyond the individual instances of AMD and Nvidia — is the possibility that this will be expanded,' said Gary Hufbauer, a senior fellow at the Peterson Institute for International Economics. 'Everything is now 'national security,' according to the new definition, which means it's all subject to export licenses and then they give you a license based on your contribution.' There are concerns that US trade agencies could begin charging fees to companies every time there's a meeting to discuss tariffs, according to people familiar with the matter who asked not to be identified discussing private deliberations. The Commerce Department's Bureau of Industry and Security, which issues export licenses, wasn't consulted about the revenue deal, according to people familiar with the matter who asked not to be identified discussing private conversations. Trump administration officials defend the idea as a smart way to generate revenue for the US government and suggest it will extend well beyond the chips sector. 'I think we could see it in other industries over time,' Treasury Secretary Scott Bessent said in an interview with Bloomberg Television on Wednesday. 'I think right now this is unique, but now that we have the model and the beta tests, why not expand it?' Bessent defended the deal and rejected any national-security concerns around the decision to sell Nvidia's H20 chip to China — something that had been earlier barred for fear of giving China a boost in the artificial-intelligence race. 'There are no national security concerns here,' Bessent said. 'We would not sell any of the advanced chips. So, the H20, I don't know whether you'd say they're four, five, six levels down the chips stack.' Either way, the deal highlights how Trump has pushed to open a wave of new revenue streams including by taking ownership shares of companies or extracting higher fees to live or work in the US. The US is weighing sales of a so-called 'gold card' residency permit, it won a 'golden share' to have direct say over corporate actions by United States Steel Corp., and it's secured investment pledges and potential revenue-sharing in country-level tariff talks. That's aside from the barrage of product tariffs that have at times left massive dislocations in globally traded markets. The matter further surprised China hawks in Congress, who have been unimpressed by the administration's reassurances. Rep. John Moolenaar, the Michigan Republican who chairs the US House Select Committee on China, questioned the legal basis for the move and suggested it does an end-run around controls put in place to limit the sale of sensitive technology to US adversaries. 'Export controls are a front-line defense in protecting our national security, and we should not set a precedent that incentivizes the government to grant licenses to sell China technology that will enhance its AI capabilities,' he said. It also raises questions about where the administration will steer the revenue. Trump has mused about issuing tariff rebate checks — though he has yet to seriously pursue the idea — while at other times he's said it would go toward narrowing the large budget deficit. The administration had debated launching a sovereign wealth fund before shelving those plans for now. It's too soon to say whether the administration will seek to revive the fund and steer revenue there, one official familiar with deliberations said. 'Trump's aides argue that these measures will strengthen America's AI leadership by maximizing its global influence and market share,' Hal Brands, a professor at the Johns Hopkins School of Advanced International Studies and a former Pentagon official, wrote in Bloomberg Opinion. 'Yet it is also possible that they will simply eat into America's innovation advantage.' --With assistance from Mackenzie Hawkins and Derek Wallbank. (Updates with details of consultation process in fifth paragraph.) Americans Are Getting Priced Out of Homeownership at Record Rates Dubai's Housing Boom Is Stoking Fears of Another Crash Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Electric Pickup Truck Boom Turned Into a Big Bust ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
7 minutes ago
- Yahoo
JPMorgan Lifts PT on Nu Holdings (NU) to $16 From $14.50, Keeps an Overweight Rating
Nu Holdings Ltd. (NYSE:NU) is one of the best NYSE stocks to buy under $20. On June 30, JPMorgan raised the firm's price target on Nu Holdings Ltd. (NYSE:NU) to $16 from $14.50, keeping an Overweight rating on the shares. A wide angle shot of a team of bankers and financial advisors evaluating an investment portfolio on a touchscreen monitor. The firm told investors that it is 'bullish on the name,' and is raising its estimates by 4% in 2025 and 2026. It reasoned that it sees tailwinds ahead that comprise resilient loan growth, along with net interest margin and credit card loan yield potentially rebounding. Headquartered in George Town, Cayman Islands, Nu Holdings Ltd. (NYSE:NU) is a provider of digital banking services. While we acknowledge the potential of NU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
7 minutes ago
- Yahoo
Middle Eastern Penny Stocks: Gulf Pharmaceutical Industries P.S.C And Two More To Watch
The Middle Eastern stock markets have been experiencing mixed performances, with some indices buoyed by hopes of a U.S. Federal Reserve rate cut while others are weighed down by weaker corporate earnings. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or less-established companies that can offer significant value when backed by strong financials. This article will highlight three such penny stocks in the Middle East, focusing on their potential for long-term growth and stability amidst current market conditions. Top 10 Penny Stocks In The Middle East Name Share Price Market Cap Financial Health Rating Big Tech 50 R&D-Limited Partnership (TASE:BIGT) ₪1.414 ₪15M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.71 SAR1.48B ★★★★★★ Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP) TRY4.75 TRY1.31B ★★★★★☆ E7 Group PJSC (ADX:E7) AED1.47 AED3B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY2.97 TRY3.2B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.45 AED392.7M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.89 AED12.25B ★★★★☆☆ Al Dhafra Insurance Company P.S.C (ADX:DHAFRA) AED4.86 AED486M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.828 AED488.43M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.937 ₪218.34M ★★★★★★ Click here to see the full list of 76 stocks from our Middle Eastern Penny Stocks screener. Here's a peek at a few of the choices from the screener. Gulf Pharmaceutical Industries P.S.C Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and internationally with a market cap of AED1.68 billion. Operations: The company's revenue segments include AED732.9 million from Planet and AED864.9 million from Manufacturing. Market Cap: AED1.68B Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown a positive shift in its financial performance, reporting a net income of AED 157.9 million for the first half of 2025 compared to a net loss the previous year. The company's debt is well-managed with operating cash flow covering 31.1% and a reduced debt-to-equity ratio from 117% to 55.9% over five years, indicating improved financial health. Despite low return on equity at 2.4%, Julphar's profitability and stable weekly volatility are promising traits for investors interested in Middle Eastern penny stocks with potential growth prospects amidst operational challenges. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Examine Gulf Pharmaceutical Industries P.S.C's earnings growth report to understand how analysts expect it to perform. Sinpas Gayrimenkul Yatirim Ortakligi Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat Anonim Sirketi in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates in the real estate sector with a market capitalization of TRY17.76 billion. Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion. Market Cap: TRY17.76B Sinpas Gayrimenkul Yatirim Ortakligi has demonstrated robust financial health, with short-term assets of TRY14.8 billion comfortably covering both its short and long-term liabilities. The company has experienced significant earnings growth, notably an 86.4% increase over the past year, surpassing industry averages. However, a substantial one-off gain of TRY5.3 billion skews recent earnings quality. While its net debt to equity ratio is satisfactorily low at 14.2%, interest coverage remains weak at 2.1 times EBIT, suggesting potential pressure in meeting debt obligations despite stable weekly volatility and reduced debt levels over five years. Unlock comprehensive insights into our analysis of Sinpas Gayrimenkul Yatirim Ortakligi stock in this financial health report. Review our historical performance report to gain insights into Sinpas Gayrimenkul Yatirim Ortakligi's track record. Oil Refineries Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.64 billion. Operations: Currently, there are no reported revenue segments for Oil Refineries Ltd. Market Cap: ₪2.64B Oil Refineries Ltd. faces challenges with a net loss of US$37 million in Q2 2025, contrasting with a profit last year. Despite this, its financial structure shows resilience; short-term assets of US$2 billion surpass both short and long-term liabilities. While the dividend yield is high at 10.22%, it isn't supported by earnings, raising sustainability concerns. Debt management has improved over five years, reducing from 127.7% to 75.3%. However, interest payments remain uncovered by EBIT and the company remains unprofitable despite shrinking losses annually by 25.8%. Management's experience offers some stability amid these hurdles. Dive into the specifics of Oil Refineries here with our thorough balance sheet health report. Explore historical data to track Oil Refineries' performance over time in our past results report. Turning Ideas Into Actions Click here to access our complete index of 76 Middle Eastern Penny Stocks. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ORL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
